Download Right heart catheterisation: how to avoid the most common mistakes

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Heart failure wikipedia , lookup

Myocardial infarction wikipedia , lookup

Coronary artery disease wikipedia , lookup

Lutembacher's syndrome wikipedia , lookup

Cardiac surgery wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Atrial septal defect wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Dextro-Transposition of the great arteries wikipedia , lookup

Transcript
Right heart catheterisation: how to avoid the most common mistakes
Dr. Michele D'Alto
Department of Cardiology
Second University of Naples
Monaldi Hospital
Via Leonardo Bianchi, 1
80131 Naples
ITALY
[email protected]
AIMS



To discuss practical issues: vein cannulation, type of catheter, catheter placement, waveform
interpretation, measurements and calculations.
To identify possible pitfalls and caveat.
To improve the skills in performing a correct diagnosis integrating RHC and other imaging
modalities.
SUMMARY
Right heart catheterization (RHC) represents the gold standard for measuring pulmonary
haemodynamics. RHC is mandatory to confirm the diagnosis of pulmonary hypertension (PH), to
assess the severity of haemodynamic impairment and to perform vasoreactivity testing in selected
patients.
PH is defined as a mean pulmonary arterial pressure (mPAP) ≥25 mmHg by RHC measured at rest,
with pre-capillary PH being defined by a pulmonary artery wedge pressure (PAWP) ≤15 mmHg and
post-capillary PH by a PAWP >15 mmHg. Among post-capillary PH, “isolated post-capillary PH”
(Ipc-PH) is defined by a diastolic pulmonary gradient (DPG) <7 mmHg and pulmonary vascular
resistance (PVR) ≤3 WU, and “combined post- and pre-capillary PH” (Cpc-PH) by DPG ≥7 mmHg
and/or PVR >3 WU.
The term pulmonary arterial hypertension (PAH) describes a group of PH characterized by the
presence of pre-capillary PH and a pulmonary vascular resistance (PVR) >3 Wood units (WU) in the
absence of other causes of pre-capillary PH such as PH due to lung diseases, chronic thromboembolic
pulmonary hypertension (CTEPH) or other rare diseases.
RHC, as an invasive diagnostic tool, is part of a complex alghorhythm for PH diagnosis. The
interpretation of invasive haemodynamics should consider the context of the clinical picture and
imaging, in particular echocardiography.
RHC is a challenging procedure requiring careful attention, meticulous measurement and extensive
expertise. In order to obtain valuable clinical information and to minimize the risk related to the
procedure RHC should be limited to expert centres.
Cannulation of a sufficiently large systemic vein is the first step for performing RHC.
The practice of using surface anatomy and palpation to identify target vessels before cannulation
attempts (“landmark technique”) is based on the supposed location of the vessel, the identification of
anatomic landmarks, and blind insertion of the needle until blood is aspirated. Depending on the site
and patient population, landmark techniques for vascular cannulation are associated with a 60% to
95% success rate. The landmark technique can be augmented by the use of ultrasound; this is
recommended in the case of jugular vein cannulation and very helpful when using the brachial vein
approach.
The gold standard for pressure and blood flow measurement of the pulmonary circulation are
respectively the high-fidelity micromanometer-tipped catheters and the direct Fick method. The fluidfilled flow-directed thermodilution catheters are much more widely used and have been demonstrated
to be accurate though with lack of precision of +/- 1/L/min for cardiac output, +/- 8 mmHg for mPAP
and -15 to +8 mmHg for PAWP. Precision on otherwise accurate measurements can be improved by
repetition and averaging. This is why it is recommended to average 3 to 5 thermodilution cardiac
output measurements with less than 10% variation, and to read pulmonary vascular pressures in
triplicate.
In clinical practice, the catheter commonly used for RHC is a balloon floatation tip catheter, known as
“Swan-Ganz” catheter.
A correct zero level set is pivotal in performing RHC. The wrong zero level set is one of the most
common mistakes and a major confounding factor during RHC. Zero level setting must be meticulous
because it represents the starting point for all pressure measurements. In fact, each pressure measured
during RHC is a difference between the pressure at the chosen zero level and the pressure in the
chamber (or vessel) where the fluid-filled catheter tip is located, assuming there is no obstruction and
no significant flow within the catheter.
The question of zero leveling was raised before the introduction of cardiac catheterization, during the
early measurements of the peripheral and central venous pressure. An ideal zero reference would be
not only independent of chest diameter but also insensitive to changes in body position and represent
a “hydrostatic indifference point”. Recently, it has been proposed a standardized reference point valid
in any body position, defined by the intersection of the mid-thoracic frontal plane with the transverse
plane passing through the fourth anterior intercostal space and the mid-sagittal plane.
Kovacs et al. assessed retrospectively the position on computed tomography the right and left atrial
centre levels in 196 consecutive patients with PH undergoing RHC, found that the centre of the left
atrium was best described by the “mid-thoracic level”. As a consequence, zeroing the system at this
level seems reasonable for the assessment of PAWP.
Accurate measurement of left ventricular filling pressure is essential to distinguish between PAH and
PH due to left heart diseases, mainly heart failure with preserved ejection fraction (HFpEF).
Commonly, PAWP is used as a surrogate measure of left atrial pressure and left ventricular enddiastolic pressure. PAWP is the pressure measured from a catheter wedged in a branch pulmonary
artery. Actually, the term “wedge pressure” derives from the measurement obtained by a “wedged”
catheter without an inflated balloon. Using an inflated balloon we measure a “pulmonary artery
occluded pressure”. Both are usually referred to as a PAWP and used indifferently, but the measured
pressures will be different if there is an increased large vein resistance (such as in sepsis for example).
In clinical practice, determination of CO and CI is typically done by either the Fick method or
thermodilution, in order of reproducibility the direct Fick is preferable to thermodilution which is in
turn preferable to the indirect Fick.
The Fick principle is based on the observation that the total uptake (or release) of a substance by the
peripheral tissues is equal to the product of the blood flow to the peripheral tissues and the arterialvenous concentration difference (gradient) of the substance. In the determination of cardiac output,
the substance most commonly measured is the oxygen content of blood thus giving the arterio-venous
oxygen difference, and the flow calculated is the flow across the pulmonary system.
This provides an easy way to calculate the cardiac output: Cardiac output = oxygen consumption /
arteriovenous oxygen difference.
Measurement of the arterial and venous oxygen content of blood involves the sampling of blood from
the pulmonary artery and from the pulmonary vein. In practice, sampling of peripheral arterial blood
is a surrogate for pulmonary venous blood.
The first step during RHC in congenital heart disease is to obtain pressure measurements at different
levels of the systemic venous return, the right heart, and the pulmonary circulation. This should
include measurements in the superior vena cava, inferior vena cava, right atrium, right ventricle (or
sub-pulmonary ventricle), pulmonary artery, and PAWP. Systemic pressures are also required to
calculate the ratio between pulmonary and systemic artery pressure. The ratio between the systemic
and pulmonary pressures and resistance may be especially useful if shunt closure is contemplated.
RHC in patients with pulmonary hypertension can be very challenging and has been associated with
serious, sometimes fatal, complications. For this reason, RHC should be performed only in expert
centres.
REFERENCES
1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk
Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W,
Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M;
Authors/Task Force Members. 2015 ESC/ERS Guidelines for the diagnosis and treatment of
pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary
Hypertension of the European Society of Cardiology (ESC) and the European Respiratory
Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology
(AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2015
Aug 29. pii: ehv317. [Epub ahead of print]
2. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jaı¨s X, Marinelli A, Barst RJ, Ghofrani HA,
Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge
S, Bremer HC, Baroke E, Rubin LJ. Complications of right heart catheterization procedures in
patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546–
2552.
3. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J
Med 2003;348:1123-33.
4. Troianos CA, Hartman GS, Glas KE, Skubas NJ, Eberhardt RT, Walker JD, Reeves ST; Councils
on Intraoperative Echocardiography and Vascular Ultrasound of the American Society of
Echocardiography. Guidelines for performing ultrasound guided vascular cannulation:
recommendations of the American Society of Echocardiography and the Society of
Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2011;24(12):1291-318).
5. Gibbs NC, Gardner RM. Dynamics of invasive pressure monitoring systems: clinical and
laboratory evaluation. Heart Lung. 1988;17:43-51.
6. Pagnamenta A, Vanderpool RR, Brimioulle S, et al. Proximal pulmonary arterial obstruction
decreases the time constant of the pulmonary circulation and increases right ventricular afterload.
J Appl Physiol. 2013;114:1586-1592.
7. Hoeper MM, Maier R, Tongers J, et al. Determination of cardiac output by the Fick method,
thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care
Med 1999;160:535-541.
8. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on
pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest.
2009;136:37-43.
9. Rich S, D'Alonzo GE, Dantzker DR, et al. Magnitude and implications of spontaneous
hemodynamic variability in primary pulmonary hypertension. Am J Cardiol. 1985;55:159-163.
10. Kovacs G, Avian A, Pienn M, et al. Reading pulmonary vascular pressure tracings. How to
handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med.
2014;190:252-257).
11. Naeije R, D'Alto M, Forfia PR. Clinical and research measurement techniques of the pulmonary
circulation: the present and the future. Prog Cardiovasc Dis
12. Guyton AC, Greganti FP. A physiologic reference point for measuring circulatory pressures in
the dog; particularly venous pressure. Am J Physiol 1956; 185: 137–141.
13. McGee SR. Physical examination of venous pressure: a critical review. Am Heart J 1998; 136:
10–18.
14. Moritz F, von Tabora D. U¨bereine Methode, beim Menschen den Druck in oberflachlichen
Venen exakt zu bestimmen [A method for determining exact superficial venous pressure in
humans]. Deutsches Archiv fur klinische Medizin 1910;98:475–505.
15. Winsor T, Burch G. Phlebostatic axis and phlebostatic level: reference levels for venous pressure
measurements in man. Proc Soc Exp Biol Med 1945;58:165–169.
16. Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart
Catheterisation. Eur Respir J 2013; 42: 1586–1594.
17. Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the
diagnosis of pulmonary vascular disease. Eur Respir J 2013;41:217–23.
18. Gerges M, Gerges C, Lang IM: How to define pulmonary hypertension due to left heart disease.
Eur Respir J 2016 and Naeije R
19. Hemnes A: The difficult diagnosis of pulmonary vascular disease in heart failure Eur Respir J
2016
20. Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary vascular pressure
tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit
Care Med 2014;190:252–257.
21. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on
pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest
2009;136:37–43.
22. Hoeper MM, Maier R, Tongers J, Niedermeyer J, Hohlfeld JM, Hamm M, Fabel H.
Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in
pulmonary hypertension. Am J Respir Crit Care Med 1999;160:535–41.
23. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jaı¨s X, Marinelli A, Barst RJ, Ghofrani HA,
Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge
S, Bremer HC, Baroke E, Rubin LJ. Complications of right heart catheterization procedures in
patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:25462552.